This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition

On February 17, 2026, Connecticut-based Braidwell disclosed a new position in Centessa Pharmaceuticals (NASDAQ:CNTA), acquiring 2,188,320 shares in an estimated $54.73 million trade. What happened In a new U.S. Securities and Exchange Commission (SEC) filing released February 17, 2026 (link), Braidwell disclosed the purchase of 2,188,320 shares of Centessa. The net position change for the quarter was $54.73 million, reflecting the new holding’s quarter-end valuation. What else to know The new stake re ...